Impact Biomedical (IBO) Debt Ratio (2022 - 2025)

Impact Biomedical (IBO) has reported Debt Ratio for 4 consecutive years, with 2.51 the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Debt Ratio rose 1365.88% year-over-year to 2.51; the trailing twelve-month figure through Sep 2025 stood at 2.51 (up 1365.88% YoY), and the FY2024 full-year result was 1.03, up 90.86% from the prior year.
• Debt Ratio climbed to 2.51 in Q3 2025 per IBO's latest filing, from 2.35 in the prior quarter.
• Across five years, Debt Ratio topped out at 2.51 in Q3 2025 and bottomed at 0.17 in Q3 2024.
• Historically, Debt Ratio has averaged 0.8 across 4 years, with a median of 0.3 in 2024.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio sank 34.41% in 2024, then soared 1365.88% in 2025.
• Over 4 years, Debt Ratio stood at 0.21 in 2022, then jumped by 151.79% to 0.54 in 2023, then surged by 90.86% to 1.03 in 2024, then soared by 143.39% to 2.51 in 2025.
• According to Business Quant data, Debt Ratio over the past three periods registered 2.51, 2.35, and 0.91 for Q3 2025, Q2 2025, and Q1 2025 respectively.